thalidomide has been researched along with Arterial Obstructive Diseases in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thalidomide has been associated with venous thrombotic events, as reported in the post-marketing surveillance reports by Celgene Corporation; as well as case reports in the literature." | 5.33 | Arterial thrombosis in four patients treated with thalidomide. ( Brown, K; Chanan-Khan, A; Hahn, T; McCarthy, PL; Paplham, P; Roy, H; Scarpace, SL; van Besien, K, 2005) |
| "Thalidomide has been associated with venous thrombotic events, as reported in the post-marketing surveillance reports by Celgene Corporation; as well as case reports in the literature." | 1.33 | Arterial thrombosis in four patients treated with thalidomide. ( Brown, K; Chanan-Khan, A; Hahn, T; McCarthy, PL; Paplham, P; Roy, H; Scarpace, SL; van Besien, K, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, N | 1 |
| Tomita, T | 1 |
| Bohgaki, M | 1 |
| Kasahara, H | 1 |
| Koike, T | 1 |
| Mamopoulos, A | 1 |
| Nowak, T | 1 |
| Luther, B | 1 |
| Scarpace, SL | 1 |
| Hahn, T | 1 |
| Roy, H | 1 |
| Brown, K | 1 |
| Paplham, P | 1 |
| Chanan-Khan, A | 1 |
| van Besien, K | 1 |
| McCarthy, PL | 1 |
3 other studies available for thalidomide and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Crystalglobulinemia manifesting as chronic arthralgia and acute limb ischemia: A clinical case report.
Topics: Amputation, Surgical; Arterial Occlusive Diseases; Arthralgia; Bortezomib; Dexamethasone; Humans; Le | 2017 |
Peripheral arterial reconstruction in a patient with thalidomide embryopathy and chronic occlusion of the femoral artery.
Topics: Abnormalities, Drug-Induced; Antiemetics; Arterial Occlusive Diseases; Chronic Disease; Constriction | 2013 |
Arterial thrombosis in four patients treated with thalidomide.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Drug Therapy, Combination; Female; Humans; Intracranial | 2005 |